TABLE 2.
HIV seroprevalence among NIDUs, New York City, 1995–1999 and 2005–2011
| 1995–1999
|
2005–2011
|
|||
|---|---|---|---|---|
| n | HIV+ n (%) |
n | HIV+ n (%) |
|
| Total | 792 (100) | 64 (8) | 1870 (100) | 300 (16)# |
| Sex | ||||
| Male | 580 (73) | 41 (7) | 1447 (77) | 209 (14)# |
| Female | 212 (27) | 23 (11) | 423 (23)# | 91 (22)*# |
| Race/ethnicity | ||||
| White | 65 (8) | 1 (2) | 103 (6) | 6 (6) |
| African American | 312 (39) | 32 (10) | 1290 (69) | 226 (18)*# |
| Hispanic | 415 (52) | 31 (7) | 477 (26) | 68 (14)# |
| Age | ||||
| <35 | 375 (47) | 23 (6) | 235 (13) | 33 (14)# |
| ≥35 | 417 (53) | 41 (10) | 1600 (87) | 259 (16)# |
| Drug use past 6 months | ||||
| Crack cocaine | 367 (46) | 42 (11) | 1376 (74) | 261 (19)# |
| Cocaine | 368 (47) | 30 (8) | 760 (41) | 91 (12) |
| Heroin | 681 (86) | 47 (7) | 702 (38) | 71 (10)# |
Significant difference by Chi-square test (comparing same row across time periods).
Significant difference by Chi-square test (largest subgroup compared with all others within time period).